Covid-19-featured

A technology developed at Vanderbilt has led to the discovery of an “ultra-potent” monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant. Read More

Pam Jones, associate vice chancellor for health and wellness and co-commander of the university’s Public Health Central Command Center, discusses asymptomatic COVID-19 testing on campus, the goal of which is to detect and forecast possible infection trends and provide early warning signs of outbreak. Read More

As a part of Vanderbilt’s COVID-19 response and in light of increasing case numbers in Nashville and the surrounding community, the university is implementing random asymptomatic testing—or “sentinel” testing—to detect and forecast possible infection trends and provide early warning signs of outbreak. Read More

See the latest updates to VU's COVID-19 dashboard. Vanderbilt maintains this dashboard to inform the university community about the number of positive COVID-19 test results for the spring 2022 semester. Read More

The Vanderbilt University Employee COVID-19 Emergency Relief Fund stands ready to assist faculty, staff and postdoctoral scholars with financial burdens that have been incurred as a result of COVID-19. Read More

Dashboard The university will launch a public COVID-19 dashboard on Wednesday, Sept. 8 and will provide weekly updates on case counts every Wednesday this fall moving forward in the COVID-19 Updates section of MyVU. The dashboard will be available on the Health and Safety Protocols website. The university had… Read More

Chancellor Daniel Diermeier and Provost C. Cybele Raver hosted a virtual town hall for faculty focused on Vanderbilt’s health and safety protocols and an update from VUMC medical experts on the current COVID-19 landscape. Read More

Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week. Read More

Chancellor Daniel Diermeier and Provost C. Cybele Raver will host a virtual town hall for faculty focused on Vanderbilt’s health and safety protocols and an update from VUMC medical experts on the current COVID-19 landscape. The live webinar also will include a moderated question and answer session. Read More

The Student Health Center will offer symptomatic COVID-19 testing on Saturdays throughout September. No appointment is necessary.  Read More

Alexandra Speros, instructor in clinical nursing, midwifery and primary care, explains the latest expert guidance that encourages pregnant women to get the vaccine at any stage of their pregnancy. Read More

Chancellor Daniel Diermeier and Provost C. Cybele Raver share a message with the campus community containing important COVID-19 information for the fall semester, including reminders about the university's health and safety protocols. Read More

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares information about the third dose of the COVID-19 vaccine, applicable to people with moderate to severe immunocompromise. Read More

A monoclonal antibody cocktail against the COVID-19 virus discovered at VUMC is the first non-vaccine modified to demonstrate the prevention of COVID-19 in a clinical trial of more than 5,000 participants. The antibody treatment could afford up to 12 months of protection from COVID-19, and preliminary laboratory findings also suggest that it can neutralize the delta variant. Read More

National and local leaders who played key roles in the original rollout and current support of the COVID-19 vaccine came together for a panel, “Vaccine Hesitancy: The Politics of Public Health in Tennessee,” hosted by The Vanderbilt Project on Unity and American Democracy and Vanderbilt University Medical Center Aug. 18. Read More

As Vanderbilt approaches the start of the 2021–22 academic year, the university is monitoring the evolving COVID-19 pandemic and public health guidance to keep the VU community as safe as possible. Read More

Vanderbilt has reinstated the COVID-19 paid leave bank, which is available to eligible staff. The paid leave bank consists of a maximum of one week, which is 40 hours, of COVID-19 leave per employee, and is in addition to an individual’s current PTO accruals. Read More

Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares what we know about when COVID-19 vaccines will be fully approved. Read More

In a spirit of expanding our knowledge, I offer the following observations about how we made decisions as an organization, built trust within our community, and bolstered Vanderbilt’s reputation as an institution willing to confront difficult circumstances with hard work, compassion and commitment. Read More

Vanderbilt University is requiring all university–employed faculty, staff and postdoctoral fellows to be fully vaccinated against COVID-19 for the 2021-22 academic year. The deadline for faculty, staff and postdocs to submit their full vaccination record is Saturday, July 31. Read More